DPP4 and diabetes mellitus: Finally, we believe this is the first clinical investigation of the effects of DPP4 inhibition on immune lymphoid cells of innate immunity, namely ILC-1, ILC-2 and ILC-3 cells in AT and blood in obese persons without diabetes.